Table 2.

Distribution of LV hypertrophy and LV mass in 191 cases and 203 controls with coronary disease

	Cases (n=191)	Controls (n=203)	p-value*
LVH (%)
All subjects	48%	25%	<0.0001
Without severe LVSD (123 cases, 165 controls)	42%	21%	<0.0001
With severe LVSD (68 cases, 38 controls)	59%	42%	0.10
Adjusted LVM†
All subjects	129 ± 45	107 ± 36	<0.0001
Without severe LVSD (123 cases, 165 controls)	120 ± 40	102 ± 32	<0.0001
With severe LVSD (68 cases, 38 controls)	145 ± 48	128 ± 43	0.07
LVH categories based in adjusted LV mass (%)			<0.0001
No LVH	52%	75%
0–9% above LVH cut-off	10%	6%
10–24% above LVH cut-off	15%	9%
≥25% above LVH cut-off	23%	9%
Joint Distribution, LVH & LVSD (%)			<0.0001
Neither	37%	65%
Severe LVSD Only	15%	11%
LVH Only	27%	17%
Both LVH and Severe LVSD	21%	8%

LVH: Left Ventricular Hypertrophy defined by quantitative measurements on echocardiogram;

LVSD: Left Ventricular Systolic Dysfunction assessed by echocardiogram

^*p values from independent samples t-test for continuous variables and chi-square test for categorical variables.

^†Adjusted LVM calculated as LVM / body surface area.